Submitted by hvacinstalltech t3_zxv51p in wallstreetbets

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population.

Will this money burning vaccine company go bankrupt?

Will Novavax come out with a innovative vaccine that rockets its stock?

Is it worth a gamble at $9? Or will it crater 50% to $4.5?

https://www.novavax.com/home/usa

https://filecache.investorroom.com/mr5ir_novavax2/187/download/3Q22-FINAL.pdf

https://www.investors.com/news/technology/nvax-stock-buy-now/

0

Comments

You must log in or register to comment.

GSAT2daMoon t1_j22kawg wrote

This is a pump and dump !

16

PDT_FSU95 t1_j24lst3 wrote

Right? That stock hit hard near beginning of pandemic and due to the fact no one needed it’s services any further…dumped. Here’s an attempt to relive the glory days!

1

VisualMod t1_j22g40y wrote

>There is a significant risk that Novavax will go bankrupt due to the large amount of money it is burning through. However, there is also a chance that the company will come out with an innovative vaccine that could send its stock soaring. At $9 per share, Novavax appears to be a risky gamble but one that could pay off handsomely if things go well.

11

Zealousideal-Dot2169 t1_j22nfai wrote

They are too far behind to their competition it both market share and the quality of their product. Novavax was a 50/50 pass a year ago but the short pressure piled on. With no catalyst its a sinker, but big news? Possible squeeze

5

Radiant-Chemical-849 t1_j26k8pf wrote

There is big squeeze potential if the malaria vaccine is approved. 80% effective in phase 2b trial. Malaria infected nearly 230 million people worldwide in 2019 alone, with an estimated 409,000 deaths.

4

Suspicious_Lake_7732 t1_j22obfu wrote

Got lucky with pandemic, look how many reverse splits in history. It might get purchased though now tbh

2

LizHurleyFan t1_j23sxou wrote

NVAX was neglected by Fauci. Not sure the reason behind it.

2

WhitePaperMaker t1_j26qplh wrote

The fda reviewers were impressed with the data presented. But the recent publication out of Australia saying it is inferior to mRNA is a nail in the coffin.

You could extrapolate the nanoflu won't compare either.

2

UltimateTraders t1_j22kylj wrote

Risk reward I'm doing puts on $mdgl

1

Itsnathan427 t1_j23w65j wrote

Do you think MDGL is going to continue going up from where it’s already at?

1

TheHerno t1_j260tis wrote

Novavax? I’ve seen (and lived) this movie twice (RSV and Covid) … hard pass for me

1